Thyrocare Technologies Limited has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board Meeting, where these results were approved, commenced at 3:35 PM and concluded at 5:40 PM on May 7, 2026. The company's statutory auditors, M/s. M S K A & Associates LLP, have issued an unmodified opinion on these financial results. A declaration from the Chief Financial Officer confirming the unmodified opinion is also enclosed. The detailed financial results and the auditors' report are available on the company's website. For the standalone results, revenue from operations for the quarter ended March 31, 2026, stood at ₹210.67 crore, with a profit after tax of ₹43.58 crore. For the full financial year, revenue from operations was ₹774.27 crore, and profit after tax was ₹148.81 crore. The consolidated results show revenue from operations for the quarter ended March 31, 2026, at ₹223.95 crore, with a profit after tax of ₹41.98 crore. For the full financial year, revenue from operations was ₹829.04 crore, and profit after tax was ₹143.57 crore. The Board of Directors has recommended a final dividend of ₹7 per equity share, subject to shareholder approval at the upcoming meeting.
